About MetroMedi
MetroMedi is a company based in Hyderabad (India) founded in 2018 by Dileep Byra Chakravarthy and Maruthi Medisetti. MetroMedi has raised $1.95 million across 3 funding rounds from investors including TGV Prasad, TGN Aruna Kumari and GP Rao. MetroMedi operates in a competitive market with competitors including Digi-Prex, Pharmallama and Apkamedical, among others.
- Headquarter Hyderabad, India
- Founders Dileep Byra Chakravarthy, Maruthi Medisetti
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Metromedi Health Technologies Private Limited
- Date of Incorporation 20 Mar, 2018
- Jurisdiction Manikonda, Telangana, India
-
Annual Revenue
$7.25 M (USD)8.69as on Mar 31, 2023
-
Net Profit
$8.91 K (USD)8.65as on Mar 31, 2023
-
EBITDA
$160.6 K (USD)23.53as on Mar 31, 2023
-
Total Equity Funding
$1.95 M (USD)
in 3 rounds
-
Latest Funding Round
$237.89 K (USD), Angel Round
Mar 27, 2021
-
Investors
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of MetroMedi
MetroMedi has successfully raised a total of $1.95M across 3 strategic funding rounds. The most recent funding activity was a Angel Round of $237.89 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MetroMedi
MetroMedi has secured backing from 4 investors, including angel investors. Prominent investors backing the company include TGV Prasad, TGN Aruna Kumari and GP Rao.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
TP
TGV Prasad |
-
|
Locked | Locked | Locked |
|
TA
TGN Aruna Kumari |
-
|
Locked | Locked | Locked |
|
GR
GP Rao |
-
|
Locked | Locked | Locked |
Investor details for MetroMedi
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MetroMedi
Investment portfolio details for MetroMedi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MetroMedi
Detailed financials for MetroMedi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Metromedi Comparisons
Peer comparison for MetroMedi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MetroMedi
MetroMedi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Digi-Prex, Pharmallama and Apkamedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Prescriptions are uploaded online for medicine delivery and reordering.
|
|
| Locked | Locked | Locked |
Online platform for the purchase of medicines
|
|
| Locked | Locked | Locked |
Operates a digital marketplace for online medicine purchases.
|
Detailed competitors of MetroMedi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Metromedi
Complete news archive for MetroMedi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MetroMedi
MetroMedi was founded in 2018 and raised its 1st funding round 1 year after it was founded.
MetroMedi is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
MetroMedi is a funded company, having raised a total of $1.95M across 3 funding rounds to date.
Annual revenue of MetroMedi is $7.25M as on Mar 31, 2023.
MetroMedi was founded in 2018 in Hyderabad, India, as an online drug store in the healthcare sector. Products focused on diabetic care, general healthcare, personal care, and nutrition are offered through its platform. Online purchases are supported with or without prescriptions, enabling access to these items for users across the region. Operations are centered on e-commerce delivery of medical and wellness goods.
MetroMedi's top competitors include Digi-Prex, Pharmallama and Apkamedical.
MetroMedi has 4 investors. Key investors include TGV Prasad, TGN Aruna Kumari, GP Rao, and Dileep Byra Chakravarthy.
The valuation of MetroMedi is $1.86M as of Mar 2021.